ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 636679 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 636679; 2) Community: the network communities that were significantly associated with the response to NSC 636679; 3) Molecule: the relationships between components within communities and NSC 636679; 4) MDR: the compounds that were significantly associated with the NSC 636679.

NSC Compound Enrichment Correlation
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0385613993886001 0.33104757
NSC 328410 Camptothecin Derivative 0.0385613993886001 0.18158464
NSC 331935 CHALCONE ANALOG 0.0385613993886001 0.39662525
NSC 332488 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)- 0.0385613993886001 -0.038605708
NSC 339137 PHYSALOLACTONE 0.0385613993886001 0.42131499
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.0385613993886001 0.30497476
NSC 56054 Pseudourea, 2,2'-(9,10-anthrylenedimethylene)bis(2-thio-, dihydrochloride, dihydrate 0.0385613993886001 0.33400187
NSC 602617 Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 0.0385613993886001 0.19031495
NSC 603071 Aminocamptothecin 0.0385613993886001 0.017730686
NSC 606499 Camptothecin Derivative 0.0385613993886001 0.033473252
Total:87  Current:59    [First] [Prev] [Next] [Last]